A new study published by UNC Family Medicine's Sarah Kowitt, Ph.D., MPH, and colleagues looked at the impact of different types of warning signs for large and premium cigars sold individually at the point of sale. The team's ...
Aug 7, 2023
0
8
In 2002, Eric Patashnik, came across a puzzling study in the New England Journal of Medicine, which found that a widely used surgical procedure for osteoarthritis of the knee worked no better than a sham procedure in which ...
Oct 17, 2017
0
0
A joint study by the University of Oulu and University of Helsinki, Finland, compared the effects of two different types of estrogen in combined contraceptives (COCs) on blood inflammatory markers and lipid levels. Similar ...
Jun 18, 2020
0
0
A major study led by the University of Birmingham has revealed that a lack of available specialist consultants in hospitals at the weekend is not the cause of the so-called "weekend effect."
Aug 2, 2021
0
77
Scientists at The Scripps Research Institute have found a new technique that should greatly speed the discovery of medically and scientifically useful antibodies, immune system proteins that detect and destroy invaders such ...
Sep 11, 2012
0
0
Cancer treatment is riddled with pros and cons, trade-offs. During October, breast cancer awareness month, the spotlight shines on endocrine therapy or "hormonal therapy." The drug, Tamoxifen, and others like it that shut ...
Oct 18, 2023
0
0
COVID-19 can be bad for anyone. For pregnant women, scientific research shows it can be worse: The disease significantly raises their odds of needing ICU care, giving birth prematurely and of dying.
Sep 29, 2021
0
1
An Imperial researcher and a chef have teamed up to create a cookbook of recipes using "hyperfoods"—ingredients with anti-cancer molecules.
Sep 8, 2020
0
4
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a team of researchers based in South ...
Feb 3, 2020
0
2
An exploratory analysis of data from the CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) randomized double-blind, placebo-controlled trial found that patients receiving interleukin-1β (IL-1β) inhibitors ...
Aug 4, 2020
0
5
